Why the study?
Do impeller-type centrifugal pumps reduce hemolysis compared to cone-type centrifugal pumps in simulated CPB, ECMO, PCPS, and LVAD conditions?
Do impeller-type centrifugal pumps reduce hemolysis compared to cone-type centrifugal pumps in simulated CPB, ECMO, PCPS, and LVAD conditions?
Answers are grounded in this paper and cite their sources.
Impeller-type centrifugal pumps cause less hemolysis than cone-type pumps under high flow/high pressure and low flow/high pressure conditions, suggesting better hemocompatibility for CPB, ECMO, and PCPS.
Different types of centrifugal pumps cause different amounts of hemolysis based on shear stress and blood exposure time. However, the hemolytic characteristics of centrifugal pumps in each clinical condition are not always clear. We compared the hemolytic characteristics of one cone-type centrifugal pump (Medtronic BioMedicus BP-80) and 2 impeller-type centrifugal pumps (Nikkiso HMS-12 and Terumo Capiox) under experimental conditions simulating their use in cardiopulmonary bypass (CPB), extracorporeal membrane oxygenation (ECMO), and percutaneous cardiopulmonary support (PCPS) as well as their use as left ventricular assist devices (LVADs). The normalized indexes of hemolysis (NIHs; grams free plasma hemoglobin per 100 L blood pumped) during use as LVADs were not significantly different among the 3 pumps. The BP-80 pump produced almost 3-fold more hemolysis than the HMS-12 and Capiox pumps during CPB, 3- to 4-fold more hemolysis during ECMO, and 5.5-fold more hemolysis during PCPS. The 2 impeller-type centrifugal pumps will therefore cause less hemolysis under high flow, high pressure difference (as in CPB) and low flow, high pressure difference (as in ECMO and PCPS) conditions than the cone-type pump.
No takes yet. Share an insight, caveat, or question.
Kawahito et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: